Zomepirac (sodium salt) structure
|
Common Name | Zomepirac (sodium salt) | ||
---|---|---|---|---|
CAS Number | 64092-48-4 | Molecular Weight | 313.71100 | |
Density | N/A | Boiling Point | 470.8ºC at 760 mmHg | |
Molecular Formula | C15H13ClNNaO3 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 238.5ºC | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of Zomepirac (sodium salt)Zomepirac sodium salt is a pyrrole-acetic acid structurally related to tolmetin sodium; a prostaglandin synthetase inhibitor. |
Name | sodium,2-[5-(4-chlorobenzoyl)-1,4-dimethylpyrrol-2-yl]acetate |
---|---|
Synonym | More Synonyms |
Description | Zomepirac sodium salt is a pyrrole-acetic acid structurally related to tolmetin sodium; a prostaglandin synthetase inhibitor. |
---|---|
Related Catalog |
Boiling Point | 470.8ºC at 760 mmHg |
---|---|
Molecular Formula | C15H13ClNNaO3 |
Molecular Weight | 313.71100 |
Flash Point | 238.5ºC |
Exact Mass | 313.04800 |
PSA | 62.13000 |
LogP | 1.51030 |
Storage condition | 2-8℃ |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300-H311-H331 |
Precautionary Statements | P261-P264-P280-P301 + P310-P311 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T |
Risk Phrases | 23/24/25 |
RIDADR | UN 2811 6.1/PG 2 |
RTECS | UX9277000 |
HS Code | 2933990090 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Limitations of hepatocytes and liver homogenates in modelling in vivo formation of acyl glucuronide-derived drug-protein adducts.
J. Pharmacol. Toxicol. Methods 41(1) , 27-32, (1999) The covalent binding of drugs or their metabolites to proteins is of increasing interest in the investigation of the toxicity of these compounds. Recent attention on biological consequences of protein... |
|
Regulating the cancer-inducing potential of non-steroidal anti-inflammatory drugs: some lessons from the 1970s and 1980s.
Soc. Sci. Med. 46(1) , 39-51, (1998) This article systematically examines government regulation of medicines in the U.K. and the U.S. with specific reference to carcinogenic risk assessment. By taking four non-steroidal anti-inflammatory... |
|
Identification of zomepirac-S-acyl-glutathione in vitro in incubations with rat hepatocytes and in vivo in rat bile.
Drug Metab. Dispos. 31(11) , 1429-36, (2003) Zomepirac (ZP), a nonsteroidal anti-inflammatory drug that was withdrawn from use, is metabolized to zomepirac-1-O-acyl-glucuronide (ZP-1-O-G), a chemically reactive conjugate that has been implicated... |
Zomax |
Zomepirac-Na |
ZOMEPIRAC SODIUM |
EINECS 264-669-2 |
sodium 5-(p-chlorobenzoyl)-1,4-dimethylpyrrole-2-acetate |
Sodium zomepirac |
Sodium 5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetate |
Zomepirac sodium salt |
Zomepirac Na. Dihydrat |
sodium [5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrol-2-yl]-acetate |
Zomepirac (sodium salt) |